Coumarin-based derivatives targeting<i>Trypanosoma cruzi</i>cruzain and<i>Trypanosoma brucei</i>cathepsin L-like proteases
Jéssica Alves Nunes, Fabrícia Nunes da Silva, Elany Barbosa da Silva, Clara Andrezza Crisóstomo Bezerra Costa, Johnnatan Duarte de Freitas, Francisco Jaime Bezerra Mendonça, Miriam A. Giardini, Jair L. Siqueira-Neto, James H. McKerrow, Thaiz Rodrigues Teixeira, Louis William Odeesho, Conor R. Caffrey, Sílvia Helena Cardoso, Edeildo Ferreira da Silva‐Júnior
Abstract
Trypanosoma cruzi (Chagas diseases – also named American trypanosomiasis) and T. brucei (human African trypanosomiasis – HAT) negatively impact public health, being endemic in several countries and leading to thousands of deaths per year.
Topics & Concepts
Trypanosoma cruziTrypanosoma bruceiChagas diseaseChemistryTrypanosomiasisProteasesAfrican trypanosomiasisCathepsinNeglected tropical diseasesVirologyBiochemistryParasite hostingPublic healthEnzymeBiologyMedicineComputer scienceGeneWorld Wide WebNursingTrypanosoma species research and implicationsBiochemical and Molecular ResearchResearch on Leishmaniasis Studies